Member Info for Skippysb01

Not convinced that CMH is a BRH target. BRH looks at medical technology.

Having said that TB clearly does see CMH as an opportunity. They were badly impacted by the pandemic. I think he see's it as a recovery opportunity.

Apologies Benster as it feels like I'm constantly disagreeing with you. I'm just putting my view forwards as I'm sure you are. I hope we all come out of this well.

Bennster - the risks are there for all to see. I don't disagree with that.

But we shouldn't discount the money that BRH made and returned to investors on the sale of RMS. So it isn't fair to suggest that they haven't realised any returns. I think the development of Pataytec and Phasefocus in particular will see returns to investors in time and I'm perhaps not in as much of a hurry as some. Those companies have reached beyond the development phase for several products making sales more likely than not.

I'm more comfortable for BRH to expand it's portfolio TBH. There are opportunities right now and with the market being so volatile, flexibility to raise funds is important.

Meant BRH not NRH.

From the previous RNS - why is NRH looking for permission to offer shares as part of purchasing positions in investment opportunities:

'The Board considers that the current volatility in markets is creating unexpected opportunities for investment in companies in line with the Company's investment strategy which would complement Braveheart's portfolio and investment objectives. The Board is working to identify undervalued technology investment opportunities and considers it needs the ability to offer consideration, either in full or in part, in ordinary shares in the Company to secure the best terms. The Company is not in the advanced stages of agreeing terms on any such investment as at the date of this announcement.'

I agree with BRH - that investment opportunities are happening now. Makes sense to me.

TB is confident. We can't know if his confidence is down to the investment opportunities he sees in the current market generally or if BRH are close to realising value from an existing investment - but his confidence must surely be a good thing.

I have had prolee on filter since forever so can't see what it writes but expect it doesn't like TB selling/it doesn't like TB buy/it doesn't like BRH investing. Am I right? Got to wonder what the motives are....

Who is Lily?

Scoter. Don't think that sell was placed at the end of the day. More likely earlier in the day and late reported.

You certainly could get more than 16:36 all day long so I think this is a trade from earlier.

That sell reported late/after hours is what has created the liquidity for the buys through the day. Late reported. I'm kinda making that up but it's a theory that makes sense to me. I agree with you Chavitravi.

A little odd today and this week with TB buying. I think we might get another RNS re Trev buying more. Why now?

If Poly intend to take over or enable a takeover.

If Poly have to make an offer after acquiring 30% and that offer has to be at least at the highest price paid in the previous year..... there is nothing stopping Poly waiting a year to clear out the high SP ahead of the RNS and work with a partner (e.g. a Pharma co) and move to buy out SNG for less than 30p a share - unless of course for some reason the SP goes north before then. In any case, considering the sums involved, I can't imagine Poly or 'a Pharma' thinking it would be a good idea pay £2+ per share for the sake of waiting it out TBH.

They have a lot of control of the SP as they did running into the P3 RNS. Effectively letter boxing the SP into a tight range. We need big news to bring in new buyers to shift the SP up. Only very encouraging Activ 2 data can give us that IMO.

Alternately if Poly just want to use high % of votes to e able to encourage a higher value takeover (because they could work with other shareholders to veto a vote on a low ball offer) then they will also stay under 30%.

So for me in any given situation - without very good news - Poly will stay under 30% and wait this out and we will not know what they intend to do.

Moz2020 - Yeah it doesnt seem to be anything new. I would expect any actual distribution of the test kit would require an RNS as it's still not formally available to end users.

Keep em coming folks. I think the question we should be asking ourselves is why TB recently bought more shares......

If I have time (I'm busy at work) I will call BRH and ask them if they know what this is.

That website...... mmmmm

Do you have some evidence to support that?

Manifesto. Poly were buying ahead of the RNS too - they didnt know then either. They still don't know. My theory is that they are looking at a takeover because they believe the science is sound and that a bigger pharma could support a trial protocol which can get this to market - I really hope that happens and he deep dive/90 day/Activ 2 could get us to that.

You are right to point out the potential for future pandemic and variants that could make this more attractive. I just don't know if I can believe SNG can make it happen. I do want to be proven wrong on that but I look on this share with far colder eyes than I have in the past.

Please understand that SNG currently do not know. This trap that we all got into ahead of that miserable RNS was to think they had a heads up on results before they told us what they were.

We have the deep dive, Activ 2 and the 90 day top line to come. SNG clearly don't think they have enough data for EUA and if they did they would tell us immediately. If the outcome of Activ2 and 90 day trial provides enough momentum then fair play but they haven't produced either yet. No chance the deep dive is enough on its own - that's all about passporting to a better trial with more favourable protocol.

4D met the primary end point. How on earth can anyone compare to the SNG RNS? SNG did not meet the primary end point. They are required to state this clearly for top line results. It isn't something you can dress up in language.

Yes I got that too.

This is why IMHO a buy out is best for us now. I have no doubt that the SNG science is sound and I think because of that a big Pharma could buy the IP and get it to market. I don't think that SNG can do it alone I'm afraid.

I bought more on Misery Monday to reduce my average (as DOC83 says - it was nothing compared to what I had previously paid) and have sold and bought that position several times since then. I now have the same number of shares I had before that fateful day but with an average of 50p rather than £1.25. I have capped the number of shares I am allowing myself to own in SNG.

My lesson learned is that I didnt sell profits ahead of that RNS. I could have sold a third and would actually be in profit now. I did have a target of £3 to sell one third ahead of the P3 readout and that was too high. Next time I'll take profit earlier no matter how good things seem. I also kick myself for not being stronger when I asked the LSE board if anyone in SNG had actually seen any of the P3 data just days before the RNS. In hindsight I had the hunch that they had not seen anything and I was right. My understanding of the protocol was spot on - my fault for not trusting myself.

I don’t think there is panic. What we have is a sell off of the value bought because of the update to the Activ 3 list that appeared to show SNG still game on for that trial. In reality we are no more or less likely to succeed than we were 2 weeks ago. A ‘delay’ is a ‘pause’ is a refactored trial etc. all semantics. If it works it will find a way through but it needs a trial protocol that can show it’s strengths and it needs the world to appreciate that new variants are coming and it may even need to be lucky to be trialled when that happens.

I now do think Poly are going to get 30% and will sell,us to the highest bidder. Big Pharma may recognise the science and be able to drive a trial that removes the uncertainty. I now think that’s the best outcome as SNG doesn’t have the weight to make this happen.

I have a modest holding now at 50p. Bottom drawer shares that might pop up with a surprise one fair day.

I’m a strong vaccine advocate as many will know.
So fully boosted. Was like flu although I had no breathlessness or even much of a cough. My partner and I have both found the symptoms hard to describe and the most significant thing we have both reported was ‘strange dreams’.

Many others off work and in local community. A more dangerous variant will close us down again in the autumn IMHO.

I’m on day 10 of Covid, still testing positive but fairly well now. First 5 days off work and now off work looking after other half and child off school with Covid. Eldest child had it first and was in bed for 2 days with fever.

NOT a cold.

I’ll be voting for.
Paraytec IP is in the bag waiting for market to want it. Happy to see investment into other opportunities rather than wait and stagnate or force sale of assets at a below par price. Todays market is a mess considering Ukraine and other impacts. Having agility to invest and be ready for a market recovery is a good thing to do.

If you are invested and vote against the proposal you are kicking yourself in the backside.